The Helmholtz Drug Research Initiative is pleased to announce its first public conference on academic drug discovery. Attracting an international audience of researchers, the conference will provide a platform to learn and hear from academic experts in the field as well as industrial scientists who collaborate with academics. With sessions on epigenetics, posttranslational modifications, innovative screens on novel targets, and RNA-based treatment modalities, this event is sure to be valuable for those who not only want to learn more about the challenges and opportunities of pursuing drug discovery in academia, but also for those who want to experience great science in this exciting field.
The meeting will take place from 8 - 9 December at the DKFZ in Heidelberg, Germany.